FR2382458A1 - Complexe antigene proteine pour bloquer les reactions allergiques - Google Patents

Complexe antigene proteine pour bloquer les reactions allergiques

Info

Publication number
FR2382458A1
FR2382458A1 FR7730521A FR7730521A FR2382458A1 FR 2382458 A1 FR2382458 A1 FR 2382458A1 FR 7730521 A FR7730521 A FR 7730521A FR 7730521 A FR7730521 A FR 7730521A FR 2382458 A1 FR2382458 A1 FR 2382458A1
Authority
FR
France
Prior art keywords
protein complex
allergic reactions
antigen protein
block allergic
block
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7730521A
Other languages
English (en)
Other versions
FR2382458B1 (fr
Inventor
Arthur Malley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of FR2382458A1 publication Critical patent/FR2382458A1/fr
Application granted granted Critical
Publication of FR2382458B1 publication Critical patent/FR2382458B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/805—Drug, bio-affecting and body treating compositions involving IgE or IgD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Complexe antigène-protéine pour le blocage des réactions allergiques. Il se compose d'au moins une fraction antigène D de la fléole des prés répondant à la formule :
FR7730521A 1976-10-12 1977-10-11 Complexe antigene proteine pour bloquer les reactions allergiques Granted FR2382458A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/731,414 US4140679A (en) 1976-10-12 1976-10-12 Antigen-protein complex for blocking allergic reactions

Publications (2)

Publication Number Publication Date
FR2382458A1 true FR2382458A1 (fr) 1978-09-29
FR2382458B1 FR2382458B1 (fr) 1982-11-19

Family

ID=24939399

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7730521A Granted FR2382458A1 (fr) 1976-10-12 1977-10-11 Complexe antigene proteine pour bloquer les reactions allergiques
FR7817302A Granted FR2382460A1 (fr) 1976-10-12 1978-06-09 Complexe antigene proteine pour bloquer les reactions allergiques

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7817302A Granted FR2382460A1 (fr) 1976-10-12 1978-06-09 Complexe antigene proteine pour bloquer les reactions allergiques

Country Status (17)

Country Link
US (2) US4140679A (fr)
JP (1) JPS5347516A (fr)
AU (1) AU510639B2 (fr)
BE (1) BE859620A (fr)
CA (1) CA1099258A (fr)
CH (1) CH636524A5 (fr)
DE (1) DE2744983A1 (fr)
DK (1) DK448677A (fr)
ES (1) ES463124A1 (fr)
FI (1) FI58501C (fr)
FR (2) FR2382458A1 (fr)
GB (2) GB1552057A (fr)
LU (1) LU78273A1 (fr)
NL (1) NL7711026A (fr)
NO (2) NO147860C (fr)
SE (2) SE427419B (fr)
ZA (1) ZA775742B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015059A2 (fr) * 1979-01-18 1980-09-03 Scripps Clinic And Research Foundation Conjugués immunochimiques: méthode et composition
EP0063064A1 (fr) * 1981-03-24 1982-10-20 Laboratoire Des Stallergenes Réactif pour le dosage radio-ou enzymo immunologique des IgE

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256732A (en) * 1978-08-15 1981-03-17 Research Corporation Modified grass pollen antigens
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
WO1981001145A1 (fr) * 1979-10-18 1981-04-30 Univ Illinois Medicaments "pro-drugs" pouvant etre actives par des enzymes hydrolytiques
US4469677A (en) * 1980-02-19 1984-09-04 Michael J Gabriel Polypeptide active immunosuppressant fraction
GB2097647B (en) * 1980-10-08 1985-07-03 Cornell Res Foundation Inc Lower allergenicity and lower thrombogenicity foodstuff and process for preparing the same
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US6022544A (en) 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
SE8303401D0 (sv) * 1983-06-15 1983-06-15 Pharmacia Ab Beredning och dess anvendning
US4702907A (en) * 1983-08-09 1987-10-27 Cornell Research Foundation, Inc. Process for inducing selective immunosuppression of antibodies
US5447722A (en) * 1983-12-12 1995-09-05 University Of Manitoba Method for the suppression of an immune response with antigen-MPEG conjugates in nonsensitized individuals
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US5026545A (en) * 1984-09-17 1991-06-25 Baxter International, Inc. Treatment of allergy and composition therefor
US5543145A (en) * 1984-09-17 1996-08-06 Baxter International, Inc. Pharmaceutical composition and method for the suppression of factor VIII inhibitor production
US4740371A (en) * 1984-09-17 1988-04-26 International Institute Of Cellular And Molecular Pathology Treatment of allergy
US4946945A (en) * 1987-06-23 1990-08-07 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US5116612A (en) * 1987-06-23 1992-05-26 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
CA2015515C (fr) 1990-01-03 1999-12-07 Jean-Marie Saint-Remy Composes pharmaceutiques contenant des complexes antigene-anticorps et leur utilisation
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
US5191066A (en) * 1990-12-07 1993-03-02 Abbott Laboratories Site-specific conjugation of immunoglobulins and detectable labels
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6656488B2 (en) * 2001-04-11 2003-12-02 Ethicon Endo-Surgery, Inc. Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2020311A1 (fr) * 1968-10-10 1970-07-10 Marsh David
FR2068465A1 (en) * 1969-08-06 1971-08-27 Beecham Group Ltd Desensitized allergy inducing material
FR2362156A1 (fr) * 1976-08-17 1978-03-17 Pharmacia Ab Substances contenant un allergene

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2020311A1 (fr) * 1968-10-10 1970-07-10 Marsh David
FR2068465A1 (en) * 1969-08-06 1971-08-27 Beecham Group Ltd Desensitized allergy inducing material
FR2362156A1 (fr) * 1976-08-17 1978-03-17 Pharmacia Ab Substances contenant un allergene

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015059A2 (fr) * 1979-01-18 1980-09-03 Scripps Clinic And Research Foundation Conjugués immunochimiques: méthode et composition
EP0015059A3 (en) * 1979-01-18 1980-12-10 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
EP0063064A1 (fr) * 1981-03-24 1982-10-20 Laboratoire Des Stallergenes Réactif pour le dosage radio-ou enzymo immunologique des IgE

Also Published As

Publication number Publication date
AU2915877A (en) 1979-04-05
FI58501C (fi) 1981-02-10
DE2744983A1 (de) 1978-04-13
FI58501B (fi) 1980-10-31
DK448677A (da) 1978-04-13
CA1099258A (fr) 1981-04-14
US4140679A (en) 1979-02-20
US4158705A (en) 1979-06-19
SE7711422L (sv) 1978-04-13
NO147860B (no) 1983-03-21
BE859620A (fr) 1978-02-01
CH636524A5 (fr) 1983-06-15
JPS5347516A (en) 1978-04-28
NO147860C (no) 1983-06-29
ZA775742B (en) 1978-08-30
FR2382458B1 (fr) 1982-11-19
NL7711026A (nl) 1978-04-14
FR2382460B1 (fr) 1982-11-19
FI772945A (fi) 1978-04-13
AU510639B2 (en) 1980-07-03
SE427419B (sv) 1983-04-11
LU78273A1 (fr) 1978-01-23
NO773465L (no) 1978-04-13
NO822838L (no) 1978-04-13
FR2382460A1 (fr) 1978-09-29
GB1552056A (en) 1979-09-05
SE8205313L (sv) 1982-09-16
GB1552057A (en) 1979-09-05
ES463124A1 (es) 1978-07-01
SE8205313D0 (sv) 1982-09-16

Similar Documents

Publication Publication Date Title
FR2382458A1 (fr) Complexe antigene proteine pour bloquer les reactions allergiques
ATE181064T1 (de) Fibrinogen-rezeptor-antagonisten
ES2112884T3 (es) Antagonistas de receptores de fibrinogeno.
DE69230013D1 (de) Fibrinogen-Rezeptor-Antagonisten
DE3686525D1 (de) Hochfeste einkristall-superlegierungszusammensetzungen.
SE8701933D0 (sv) Tetrahydronaphthalinderivate
FR2354316A1 (fr) Nouveaux agents de contraste iodes non-ioniques
IT8622630A0 (it) Anticorpi monoclonali crossreattivi e cross-protettivi contro sierotipi di p. aeruginosa.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
ATE82857T1 (de) Interleukin-2-zusammensetzungen.
DK226889D0 (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
FR2416251A1 (fr) Utilisation de colorants hydrosolubles de la serie du benzoxanthene pour la preparation d'encres fluorescentes
IT1221940B (it) Anticorpi monoclonali contro flagelli di pseudomonas aeruginosa
FR2375263A1 (fr) Terpolymeres d'acrylonitrile-styrene-indene
FR2379577A1 (fr) Colorants de thiacyanine-betaine pour la sensibilisation au bleu d'emulsions photographiques
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
FR2375188A1 (fr) Pour : nitro-amines utilisables comme composantes de diazotation
BE852011A (fr) Preparation galenique d'immunoglobuline
FR2362865A1 (fr) Derives de la 2,2'-cyclocytidine, leur preparation et leurs utilisations therapeutiques comme agents anti-cancer
FR2384495A1 (fr) Composes alcanoylanilides et leur preparation
FR2384744A1 (fr) Derives alcanoylanilides et leur preparation
FR2362901A1 (fr) Colorants methiniques, leur obtention et leur application
FI862001A0 (fi) Krok foer fiskande i vatten med undervattensvegetation.
ATE61936T1 (de) Konjugate von proteinen mit antikrebsmitteln.
SU1438172A1 (ru) Изоамил(2,2-дихлорвинил)формаль, обладающий противовоспалительной активностью

Legal Events

Date Code Title Description
ST Notification of lapse